A precise, accurate and rapid HPLC-UV method for simultaneous determination of fat-soluble vitamins (vitamin D3, E-acetate, K1, β-carotene, A-palmitate) and coenzyme Q10 was developed and validated according to ICH guidelines. Optimal chromatographic separation of the analytes in minimal analysis time (8 min) was achieved on a Luna C18 150 × 4.6 mm column using a mixture of acetonitrile, tetrahydrofuran and water (50:45:5, v/v/v). The described reversed phase HPLC method is the first published for quantification of these five fat-soluble vitamins and coenzyme Q10 within a single chromatographic run. The method was further applied for quantification of the analytes in selected liquid and solid dosage forms, registered as nutritional supplements and prescription medicines, which confirmed its suitability for routine analysis.
Introduction
Fat-soluble vitamins (FSVs) are essential for a variety of biochemical and physiological functions in human body, such as epithelial cell differentiation and vision (vitamin A), calcium and phosphate homeostasis (vitamin D), antioxidative protection in cell membranes (vitamin E) and blood coagulation (vitamin K). 1, 2 As FSV, with the exception of vitamin D3, cannot be obtained by endogenous synthesis, food or vitamin preparations are their main sources. Due to the large number of commercially available vitamin preparations and their widespread use, the quality control of these preparations is extremely important, especially because of the risk of toxicity from excessive intake of vitamins A and D. 3 HPLC methods, coupled with different detection techniques: UV, [4] [5] [6] [7] [8] [9] [10] [11] [12] FLD, 6 ECD, 13 and MS 5, 14 offer the best approach to accurate content determination of the main FSVs in foods, pharmaceuticals and nutritional supplements. The published HPLC-UV methods for quality control of preparations containing FSVs are quite limited in terms of separation and simultaneous determination of FSVs, 4, 5, 7, 8, 11 often have run time longer than 15 min [4] [5] [6] 9, 12 and generally require complicated and time-consuming sample preparation. 11, 12, 15, 16 Further on, to our knowledge none of the published HPLC methods offer simultaneous determination of FSVs and also β-carotene and coenzyme Q10, which are often found along in medicines and nutritional supplements.
We aimed to develop rapid, accurate, precise and selective HPLC-UV method for simultaneous quantification of FSVs (in their most commonly used forms: A-palmitate, D3, E-acetate, K1 and A provitamin -β-carotene) and coenzyme Q10, using simple and fast extraction procedures (without alkaline saponification or solid phase extraction). The optimised HPLC method was successfully validated according to the ICH guidelines. In addition, medicines and nutritional supplements in liquid and solid dosage forms were analysed to confirm the adequacy of the method.
Experimental

1. Chemicals and Reagents
All FSVs (vitamin A-palmitate, D3, E-acetate, K1 and β-carotene), butylated hydroxytoluene (BHT), anhy-Raku{a et al.: Novel HPLC-UV Method for Simultaneous ... drous ferric chloride, n-hexane, 85% orthophosphoric acid (H 3 PO 4 ) and HPLC grade: acetonitrile,methanol and tetrahydrofuran (THF) were purchased from Sigma-Aldrich (Steinheim, Germany). Coenzyme Q10 (CoQ10) was obtained from Kaneka Corporation (Osaka, Japan). Ultra-pure water was obtained through a Milli-Q water purification system A10 Advantage (Millipore Corporation, Bedford, MA, USA).
Instrumentation and Chromatographic Conditions
Chromatographic analysis was performed on an Agilent 1100/1200 series HPLC system (Agilent Technologies, Waldbronn, Germany) equipped with UV-VIS detector and ChemStation data acquisition system. Chromatographic separation was performed on a reversed-phase Luna C18 (2) 150 × 4.6 mm, 5 μm particle size column (Phenomenex, Torrance, USA) at 25 °C using acetonitrile-tetrahydrofuran-water (50:45:5, v/v/v) as a mobile phase at flow-rate of 1 mL/min. Injection volume (Vinj) was 20 μL for all tested samples, except for samples from Preparation 2 and 3, where it was adjusted to 3 and 5 μL, respectively. Detection was carried out at 270 nm.
3. Preparation of Standard Solutions
Standard solutions of FSVs and CoQ10 were prepared fresh daily by dissolving appropriate amounts in 0.05% (m/v) solution of BHT in n-hexane. Nine calibration standards were prepared as mixtures of all tested compounds in 0.05% (m/v) solution of BHT in n-hexane in different concentration ranges for different analytes, selected considering the concentrations and proportions of the analytes in the investigated pharmaceutical formulations (Table 1) . Quality control (QC) samples at three concentration levels were prepared by diluting separately prepared stock solutions with 0.05% (m/v) solution of BHT in n-hexane (Table 1) . Prepared calibration standards and QC samples were evaporated to dryness under a stream of nitrogen at 40 °C (TurboVap LV, Caliper, Hopkinton-MA, USA). Dry residues were reconstituted in 1.0 mL of 0.01% (m/v) solution of BHT in mobile phase.
4. Method Validation
The method was validated according to ICH guidelines Q2(R1) 17 in terms of selectivity, linearity, limit of quantification, precision, accuracy, recovery, sample stability and robustness.
Method selectivity was assessed by comparing chromatograms of individual standard solutions, mixture containing all standards, all used solvents and several common excipients found in commercial preparations (citric acid, sodium hydrogen phosphate, glycerol, propylene glycol, sodium benzoate, methyl-and propylparaben).
Linearity was evaluated based on nine calibration standards ( Table 1 ). The procedure was repeated three times, using different stock solution, for three consecutive days of the validation. Injection volume during validation was 20 μL. Linearity was determined based on least-square linear regression. The acceptance criterion for determination coefficient was R 2 > 0.999. Limit of quantification (LOQ) was calculated from the regression lines, using the following equations: LOQ = (10 × σ) / S, where σ is the standard deviation of the intercept, S is the average slope of the calibration curve.
Accuracy and precision were examined in terms of repeatability, precision and accuracy (intra-and interday) during three consecutive validation days, based on three QC samples covering low (QC L ), medium (QC M ) and high ranges (QC H ) of the calibration standards (Table 1). QC samples were prepared separately, in triplicate, each day of the validation. Injection repeatability was evaluated on three concentration levels by re-injecting the same QC sample six times. Intra-and inter-day pre- cision (relative standard deviation -RSD) was expected to be not more that 5% (2% for injection repeatability) and intra-and inter-day accuracy (ratio (%) between calculated concentration for the obtained QC response based on the line equation and nominal concentration, which was calculated considering the sample preparation) within ± 5%. Accuracy of the injection volume variations was evaluated by re-injecting different volumes (3, 5, 15, 25 and 30 μL) of the same QC sample three times and comparing it proportionally to the nominal value (injection volume 20 μL) and was expected to be within ± 5%. Sample stability was evaluated at three concentration levels (QC) and additionally in samples from Preparation 6 (tablets) and Preparation 7 (capsules) at 25 °C for two days (at 0 and 24 h) and was expressed as ratio between the concentration at 24 h and the concentration at time 0. The acceptance criterion was 100 ± 5%.
Method recovery was determined by spiking preparation solutions with approximately the same amount of the analytes, as contained in the preparations, in triplicate. Non-spiked preparations and standard solutions containing the added amounts were separately analysed. Average recoveries were calculated by the formula: recovery (%) = 100 × (concentration found in spiked sample -concentration found in unspiked sample) / added concentration.
The robustness of the method was investigated by deliberate modifications made to chromatographic conditions and sample preparation procedure. In sample preparation procedure for preparations in solid dosage form, different vortexing times (10 ± 5 min), shaking times (30 ± 10 min), sonication times (10 ± 5 min) and different drying temperature (40 ± 5 °C) were tested. To evaluate robustness in terms of chromatographic conditions, different injection volumes (20 ± 5 μL), column temperatures (25 ± 2 °C), flow rates (1.00 ± 0.05 mL/min), detection wavelengths (270 ± 5 nm) and mobile phase compositions acetonitrile-tetrahydrofuran-water (50.50:44.55:4.95 and 50:45:5 v/v/v) were tested.
5. Sample Preparation of Nutritional Supplements and Medicines
The validated method was further applied to assay vitamins and CoQ10 content in commercially available pharmaceutical preparations: three solutions, three tablets and two soft-shelled capsules, registered as medicines or nutritional supplements. Each preparation was prepared and analysed in triplicate.
Liquid preparations were either directly analysed (Preparation 2 and 3) or diluted 100-fold with 0.01% (m/v) solution of BHT in mobile phase prior to analysis (Preparation 1). The extraction procedure for tablets was as follows: one tablet (whole or powdered depending on the preparation) was added to 2.0 mL of 0.1% H 3 PO 4 into a centrifuge tube and vortexed for 10 min. Organic solvent 
Results and Discussion
1. Optimization of Chromatographic Conditions
The main objective of the study was to obtain optimal analytical method in terms of sample preparation and chromatographic conditions for simultaneous quantification of FSVs and CoQ10 in medicines and nutritional supplements. Chromatographic conditions were optimized in order to achieve baseline separated, symmetric peaks of the target analytes in minimal analysis time. Selection of stationary phase (various C18 reversed phase analytical columns) was based on our experience and previous research. Several mixtures of acetonitrile and methanol in isocratic and gradient modes were tested and found suitable for chromatographic separation of all tested analytes except CoQ10, which eluted only after THF was added to the mobile phase. Various mixtures of acetonitrile, THF and water at flow rates 0.5-2.0 mL/min and column temperatures 25-40 °C and detection wavelengths 210-325 nm were tested to optimize the chromatographic separation of all tested vitamins as well as both reduced and oxidized form of CoQ10. Detection wavelength 270 nm was selected as optimal compromise between absorbance of the individual analytes and their concentration in the tested preparations, with particular reference to vitamins D3 and K1, which have the lowest contents in the tested multivitamin preparations. Optimized chromatographic conditions resulted in symmetric and separated peaks with a short run time (Figure 1) . The obtained run time is considerably shorter in comparison to other similar published HPLC-UV methods. [4] [5] [6] 9, 12 
2. Optimization of Sample Preparation
The optimised HPLC method was further applied to evaluate the content of FSVs and CoQ10 in commercial pharmaceuticals with particular attention to sample preparation, as a crucial step in the analysis of medicines and nutritional supplements. We aimed to develop simple and fast extraction procedure with a minimal number of steps and solvent consumption.
The extraction procedure for tablets was adjusted from Temova and Ro{kar's method for vitamin D3 extraction, 18 which comprised of addition of 0.1% H 3 PO 4 to two tablets, vortexing for 2 min, subsequent addition of methanol (8.0 mL), sonication (10 min), vortexing (2 min) and centrifugation of the samples. In order to determine the optimal method, studies were done with (2.0 mL) and without the addition of 0.1% H 3 PO 4 to one powdered tablet. Hereafter, different shaking times (0, 2, 4, 5 and 15 min with vortex mixer and 30 min with rotary mixer), organic solvents (methanol, n-hexane and mobile phase), sonication times (0, 5, 10, 15 min), further shaking times (0, 2 and 4 min with vortex mixer and 30 min with rotary mixer) and centrifugation times (0, 10 and 15 min) at 25°C and 5000 rpm were tested. The best extraction in terms of method recoveries was achieved with the addition of 2.0 mL of 0.1% H 3 PO 4 into a centrifuge tube with one tablet, vortexing for 10 min and addition of 0.05% (m/v) solution of BHT in n-hexane (8.0 mL), before their further sonication (10 min) and vortexing (2 min). Samples were then centrifuged for 10 min at 25 °C and 5000 rpm.
The optimization of the extraction procedure for soft-shelled capsules started with investigation of extraction organic solvents (anhydrous ethanol, methanol, n-hexane, different mixtures of n-hexane and methanol, mobile phase, n-hexane:THF = 95:5 (v/v)), to determine the optimal solvent, which was found to be n-hexane with 0.05% (m/v) BHT : THF = 95:5 (v/v). THF was added to solve the issue of poor solubility of β-carotene. Further on, sonication time (0, 5, 10, 15 min), shaking time (15, 30, 45, 60 min) and reconstitution solvent (methanol, mobile phase and 0.01% (m/v) solution of BHT in mobile phase) were tested in order to obtain optimal recoveries of the extraction procedure. The final extraction parameters (10 min sonication, 30 min shaking and 0.01% (m/v) solution of BHT in mobile phase as reconstitution solvent) provided suitable recoveries and sample stability of all analytes (Table 3 ).
Method Validation
Selectivity of the method was confirmed as no interfering peaks were found at retention times of the selected analytes (Figure 1) . The standard calibration curves were linear over concentration ranges as presented in Table 2 . Appropriate linearity was achieved with the addition of lipophilic antioxidant -BHT, especially for vitamin A-palmitate (R 2 = 0.9945 without BHT) and β-carotene (R 2 = 0.9935 without BHT). As shown in Table 2 on the example of QC medium sample, intra-day, inter-day and accuracy of the injection volume variations was better than ± 5% at all times, which is within the defined acceptance criteria. Similarly, intra and inter-day precision were below 3% in all cases and injection repeatability was less than 2% (Table 2) . Sample stability after 24 h was assessed in order to ensure that the obtained concentration results adequately reflect those directly after sampling. Stability of all tested analytes in QC samples and samples from Preparation 6 and 7 after 24 h in the autosampler at 25 °C was within the defined acceptance criteria 100 ± 5%. Such sample stability in QC samples was obtained after the addition of BHT, especially for vitamin A-palmitate and β-carotene, which were found subject to extensive degradation without appropriate stabilization with BHT (22 and 70% after 24 h for vitamin A-palmitate and β-carotene, respectively). Method was found robust to slight changes in both chromatographic and sample preparation parameters. The obtained results from samples prepared with deviations in the sample preparation procedure, were accurate (100 ± 5%) and precise (RSD < 5%). In all varied chromatographic conditions the resolution between the studied compounds was not altered, demonstrating the robustness of the method.
4. Assay in Nutritional Supplements and Medicines
In order to test the applicability of the developed and validated HPLC method to commercial multi-vitamin preparations, six pharmaceutical preparations, registered as medicines and two nutritional supplements in various dosage forms (solutions, tablets, soft shelled capsules) were tested to evaluate the content of the analytes in relation to the value claimed on the label. Liquid preparations were either directly analysed (Preparation 2 and 3) or diluted with 0.01% (m/v) solution of BHT in mobile phase prior to analysis (Preparation 1). Samples from tablets and capsules were prepared according to the optimised extraction procedure (Section 3.2) Representative chromatograms of samples from all three dosage forms are presented in Figure 2. The results for average contents and calculated method recoveries are presented in Table 3 . High recoveries and low standard error values (Table 3) confirmed the suitability of the established HPLC method for quantification of the target analytes in liquid and solid preparation without any pre-treatment (Preparation 2 and 3) or after a simple and rapid pre-treatment (other preparations).
Conclusions
The main novelty in our approach is the developed HPLC method, which to our knowledge, is the first published method for simultaneous determination of five fatsoluble vitamins (A-palmitate, D3, E-acetate, K1 and A provitamin -β-carotene) and coenzyme Q10. Moreover, analysis time of only 8 min is favourable in comparison to other published HPLC-UV methods for determination of fewer fat-soluble vitamins. The obtained results from the assay in commercial nutrition supplements and medicines confirmed that the method is appropriate for routine analysis and quality control of multi-vitamin products in pharmaceutical and health food industries. Considering 
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Capsules that most of the tested preparations had considerably higher contents than labelled (up to 150%), quality control of these preparations is of extreme importance.
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